Sahajanand Medical Technologies (SMT) is establishing its European headquarters which will have a state-of-the-art Research, Development and Innovation Centre in Galway- Ireland, creating 50 jobs over five years.

SMT is largest developer and manufacturer of minimally invasive coronary stent systems in India and supplies to around 60 countries in Europe, Asia, MENA and Latin America. The company has received numerous awards for its breakthrough innovations and quality that have led to more thinner and flexible DES with good long term clinical results.

The project is supported by the Department of Jobs, Enterprise & Innovation through IDA Ireland.

Commenting on the launch, Ganesh Sabat, CEO of SMT, said, "We were pioneers amongst Indian medical device companies and have seen tremendous value in investing in research & development (R&D). Our early investments in R&D, beginning one and half decades ago, enabled us to make technology our key differentiator and develop a robust coronary stent for the world. Our core strength lies in our ability to excel in developing technologically complex products through focused teams."

Speaking at today's announcement, SMT's Western European Head, Mr. Gaurav Goel said: "We were pioneers among Indian medical device companies to identify tremendous value in investing in research & development (R&D). Our core strength lies in our ability to excel in developing technologically complex products through focused teams. With this centre, we hope to tap into the excellent talent pool available in Galway to make further enhancements in existing products and to develop new and innovative products."